George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
More interesting. Some positive news expected
Very quiet. Look forward to progress update next week or soon after
Apart from anything else this stock has one of the best long term trend charts on Aim or anywhere else come to that.
Tipped in last week's Investors Chronicle.
Seemingly fresh BUYING interest - have the shares been tipped again. Any thoughts please?
Today (6th Jan) was the last opportunity for eligible share holders to participate in the Magnetic share purchase plan. The AVG Capital Raising general meeting of Magnetica is on 16th January. If approved AVG could end up with a holding in Magnetica of between 52% & 69%.
Avingtrans has announced today its further investment in Adaptix. It is also involved at the same time presently making a further investment in Magnetica its Medical Division. Likely bringing their complementary technologies closer together in application. It is not entirely clear from the announcement what is meant by the intention being to lead Adaptix to a successful exit planned for 2024 but it would suggest possibly a listing on the stock market. If so might Magnetica become part of that too? Any other views please?
Magnetica majority owned by Avingtrans as its Medical Division is seeking approval to raise new capital while also converting its debt owned by Avingtrans into new Equity. Magnetica shares in issue could increase from around 339m to 562m with Avingtrans holding being somewhere between 52% & 69% of the larger capitalization.
Very interesting is that the fund raising documentation mentions amongst other things the potential of collaboration to evaluating the opportunity to combine the images produced from Magnetica's Cryogen-Free MRI System & Adaptix PLC's DT ( Digital Tomosynthesis) imaging system. Avingtrans holds around 11% of the Adaptix PLC's equity.
This share has really tanked over the last week or so and I cannot see any particular reason for it, other than general market malaise. Am I missing something?
AVG tipped by ST in the IC yesterday, so the price drops.
Any thoughts please as to the reason for recent buying interest? Have they been tipped anew?
They have alot up their sleeve,supplying the nuclear industry is a big winner,especially when you are the only company to manufacture what they need.
Curious as to reason for AVG Share Price up almost 7% today. Any suggestions as to why?
When people see the enormity of the contract for nuclear shielded boxes,then that should give an uplift.
One of very few risers so far on the day Putin invades Ukraine. Surely that has to be an encouraging sign
Steady as she goes. Short term would benefit from news of positive development regarding Luton site and/or otherwise an acquisition seen as well conceived by the market. It is likely to be developments involving the Medical activities (Mini-MRI scanners) said to be complementary to Adaptix ( CTI) being better recognised by the market that will provide the next leg up in the SP. They say "First products for clinical testing are expected to be ready by Q4 2022" Not that far off!
Maybe not stellar, but still pretty encouraging interims in a difficult climate; Perhaps the fall in share price presents a buying opportunity? Any thoughts/opinions?
Avingtrans finds troubled engineering firms, buys them at a cut-price rate, turns them round and sells them at a profit.
The shares are £4 each and should increase in value as Avingtrans management is highly experienced and has delivered more than a decade of robust returns and dividend growth.
Some businesses are kept for years. Some are sold relatively quickly. Many are bundled together to create a whole that is more than the sum of its parts.
Metalcraft, for instance, originally focused on the medical and scientific markets but merged with another firm in 2013 and has since become one of the leading providers of nuclear waste containers.
Avingtrans has many other businesses in its stable. Booth Industries makes exceptionally durable doors for use in high-pressure environments, including HS2 tunnels, where doors will need to stay firm as trains rattle past at 225mph.
Bolton-based Booth was on the brink of collapse when Avingtrans acquired the firm for £1.8million in 2019. Today, Booth is profitable and will probably be sold for a significant sum in the next year or so.
Avingtrans also rescued Hayward Tyler, an AIM business that fell into difficulties. Acquired in 2017, the firm is now in rude health, supplying pumps and motors for use in tough environments, such as offshore oil rigs, solar power plants and chemical processing sites.
Avingtrans chief executive Steve McQuillan, an engineer by background, has been at the helm since 2008. Finance director Stephen King, another qualified engineer, has worked at the firm for even longer, joining in 2002.
Over the years, the two have bought and sold dozens of businesses, always centred on complex engineering products that are hard to replicate and are in demand year in, year out.
What did MAIL-ON-SUNDAY HAVE TO SAY? Any new angle? Interim Results due this Wednesday.
Development site sale? Progress with Medical activities?
tipped in mail on Sunday 20/02/22
May be a silly question ...... but can anyone explain todays strange spike? Seems to have shot up 20% to 545 based on a buy at this price, then jumped back down after a buy at 454. Implies someone bought at a 20% premium?
Agreed. Good position for another acquisition.
Lovely quiet share. Yet we've doubled since I came not much over a year ago. People knock Simon Thomson, but he's done well for me. In the main! Much better than the rest of IC.
Simon Thompson of Investors Chronicle has done another write up following Thursdays final results.
The target price has been nudged up to 520 from 500.
The article makes mention of the following:
72p cash per share;
Outline planning permission for the Luton site which (unnamed) brokers reckon will sell for around £11m before the end of the financial year;
Prospect of selling Booth's for around £10m;
Currently on an enterprise value to operating profit ratio of 14.5x, a 20% discount to engineering peers;
4p dividend;
Strong current order book.
To me it looks as though the board are taking cash from the subsidiaries they've improved with a view to buying another underperformer and turning that around.
On past performance, this would be a move I welcome.
All sounds good